Catabasis Pharma (CATB) Tops Q3 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Catabasis Pharma (CATB) Tops Q3 EPS by 9c

Catabasis Pharmaceuticals Reports Third Quarter 2015 Financial Results and Recent Corporate Highlights

November 12, 2015 4:10 PM EST

-- MoveDMDSM trial of CAT-1004 in Duchenne Muscular Dystrophy (DMD) Progressing --

-- Orphan, Rare Pediatric Disease and Fast Track Designations Received for CAT-1004 in DMD --

-- Phase 2a Trial for CAT-2054 in Hypercholesterolemia Actively Recruiting --

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a clinical-stage drug... More